Kindstar Globalgene Technology, Inc. (9960.HK) HKSE

1.15

-0.03(-2.54%)

Updated at December 24 12:08PM

Currency In HKD

Kindstar Globalgene Technology, Inc.

Address

Biolake D2-1

Wuhan,

China

Phone

86 40 0736 1666

Sector

Healthcare

Industry

Medical - Care Facilities

Employees

3011

First IPO Date

July 16, 2021

Key Executives

NameTitlePayYear Born
Shiang HuangFounder, Executive Chairman, Chief Executive Officer & Chief Medical Officer935,9941960
Haijie ChaiExecutive Director, CFO & Company Secretary790,4681979
Zanbing TuCo-Founder, Executive Director & Chief Operating Officer935,9941973
Fan Jian-BingChief Scientific Officer0N/A

Description

Kindstar Global (Beijing) Technology, Inc. provides medical esoteric testing services to hospitals in China. Its services include medical research, drug trial, and translational medicine research services for physicians, medical science and technology institutions, specialty and general hospitals, and pharmaceutical companies. The company's lab platforms comprise flow cytometry, cytogenetic, medical genomics, molecular biology, hematopathology, mass spectrum, pathology, clinical immunology, microbiology, and scientific research laboratories. It provides tests in blood, tumor, and genetics; and cardiovascular, cerebrovascular, infectious, and autoimmune diseases, as well as in internal medicine, surgery, gynecology, pediatrics, and other specialties. The company was founded in 2003 and is headquartered in in Wuhan, China.